Ross Breckenridge, FRCP, PhD

Dr. Ross Breckenridge, CEO of Arjuna Therapeutics. is a physician, cardiac biologist and biotech executive who trained in medicine at  Oxford University and was later awarded a PhD at Cambridge University. For nearly two decades, Ross held academic and clinical positions at the UK National Institute for Medical Research. He went on to train as a clinical pharmacologist at University College London. He then moved into biotech leadership, serving as chief medical Officer and CEO at Silver Creek Pharmaceuticals, where he advanced regenerative therapies for acute and chronic diseases. Now as CEO of Arjuna Therapeutics, Ross is pioneering a novel approach to precision oncology, therapeutic molecular clusters.